Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow Print PDF (605K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (18)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Hanke, T.
Right arrow Articles by Larraga, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hanke, T.
Right arrow Articles by Larraga, V.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 2003, Vol. 31, No. 16 4917-4928
© 2003 Oxford University Press

Cloning, functional analysis and post-transcriptional regulation of a type II DNA topoisomerase from Leishmania infantum. A new potential target for anti-parasite drugs

Tobias Hanke, María J. Ramiro, Sonia Trigueros1, Joaquim Roca1 and Vicente Larraga*

Centro de Investigaciones Biológicas C.S.I.C., Velázquez 144, Madrid 28006, Spain and 1 Instituto de Biología Molecular de Barcelona, C.S.I.C., Jorge Girona Salgado 18–26, Barcelona 08034, Spain

*To whom correspondence should be addressed. Tel: +34 91 5611800; Fax: +34 91 5627518; Email: vlarraga{at}cib.csic.es

We identified a type II topoisomerase enzyme from Leishmania infantum, a parasite protozoon causing disease in humans. This protein, named Li topo II, which displays a variable C-terminal end, is located in the kinetoplast. The cloned gene encoding Li-TOP2 compensates for the slow growth of topo II-deficient mutants of Saccharomyces cerevisiae, resulting in a catalytically active DNA topoisomerase in yeast. Analysis of the specific mRNA levels of the Li-TOP2 gene showed variations throughout the parasite cell cycle in synchronized cells as well as between the distinct forms of the parasite. Thus, the enzyme had higher levels of mRNA expression in the highly infective intracellular form of the parasite, the amastigote, than in the extracellular promastigote form, suggesting a relation with the distinct developmental and infectious phases of the protozoon. In addition, western blot analysis showed differences in protein expression between the proliferative and non-proliferative forms of L.infantum promastigotes, which displayed similar levels of mRNA. This indicated possible post-transcriptional regulation mechanisms. The data suggest that Li topo II has a part in DNA decatenation and probably at the initial stages of proliferation in the intracellular form of L.infantum, a parasite that has to proliferate into the host macrophage to survive its hostile environment in its first moments of intracellular infection.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
A. Vologodskii
Theoretical models of DNA topology simplification by type IIA DNA topoisomerases
Nucleic Acids Res., June 1, 2009; 37(10): 3125 - 3133.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Kulikowicz and T. A. Shapiro
Distinct Genes Encode Type II Topoisomerases for the Nucleus and Mitochondrion in the Protozoan Parasite Trypanosoma brucei
J. Biol. Chem., February 10, 2006; 281(6): 3048 - 3056.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
A. Zick, I. Onn, R. Bezalel, H. Margalit, and J. Shlomai
Assigning functions to genes: identification of S-phase expressed genes in Leishmania major based on post-transcriptional control elements
Nucleic Acids Res., July 28, 2005; 33(13): 4235 - 4242.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.